Stifel Canada Issues Positive Estimate for QIPT Earnings

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Equities research analysts at Stifel Canada upped their Q4 2025 earnings estimates for shares of Quipt Home Medical in a report issued on Tuesday, February 11th. Stifel Canada analyst J. Keywood now forecasts that the company will post earnings of $0.03 per share for the quarter, up from their previous estimate of $0.02. The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Quipt Home Medical Stock Performance

NASDAQ:QIPT traded down $0.03 during midday trading on Thursday, reaching $2.97. 52,739 shares of the company traded hands, compared to its average volume of 119,482. Quipt Home Medical has a twelve month low of $2.30 and a twelve month high of $4.98. The firm has a market capitalization of $127.98 million, a price-to-earnings ratio of -19.80 and a beta of 0.57. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.20 and a quick ratio of 0.86. The company has a fifty day moving average price of $2.90 and a 200 day moving average price of $2.84.

Institutional Trading of Quipt Home Medical

Several large investors have recently added to or reduced their stakes in the business. Forager Capital Management LLC grew its position in Quipt Home Medical by 77.7% in the 3rd quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company's stock valued at $12,200,000 after buying an additional 1,833,590 shares in the last quarter. Kanen Wealth Management LLC bought a new position in Quipt Home Medical in the 4th quarter valued at about $4,346,000. Royce & Associates LP boosted its holdings in shares of Quipt Home Medical by 15.8% in the third quarter. Royce & Associates LP now owns 1,768,789 shares of the company's stock valued at $5,165,000 after acquiring an additional 240,980 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Quipt Home Medical by 74.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 493,858 shares of the company's stock valued at $1,506,000 after acquiring an additional 210,153 shares in the last quarter. Finally, Russell Investments Group Ltd. boosted its holdings in shares of Quipt Home Medical by 14.3% in the fourth quarter. Russell Investments Group Ltd. now owns 910,618 shares of the company's stock valued at $2,777,000 after acquiring an additional 113,682 shares in the last quarter. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, VP Patrick Dennis Gamble purchased 17,000 shares of the company's stock in a transaction on Thursday, December 26th. The shares were bought at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the purchase, the vice president now owns 40,057 shares of the company's stock, valued at $98,139.65. This trade represents a 73.73 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 13.40% of the company's stock.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.